CIK 0001540159
- Non-accelerated filer
- Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 905-475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $5.23 ($10,460)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $5.25 ($15,750)
- 4 Open-market buy President bought 3,500 shares at $5.19 ($18,165)
- 4 Open-market buy President bought 4,500 shares at $5.08 ($22,860)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $5.16 ($25,800)
- 4 Open-market sale Director sold 7,992 shares at $7.25 ($57,942)
- 4 Option exercise Director acquired 1,218 shares (option exercise)
Page 7 of 14 · 261 filings